Difference between revisions of "Part:BBa K4765118"

m
 
(4 intermediate revisions by 2 users not shown)
Line 1: Line 1:
  
__NOTOC_
+
__NOTOC__
  
 
<partinfo>BBa_K4765118 short</partinfo>
 
<partinfo>BBa_K4765118 short</partinfo>
Line 16: Line 16:
  
 
===Usage and Biology===
 
===Usage and Biology===
Biosynthetic route of MAA initiates with the generation of 4-deoxygadusol (4-DG) from sedoheptulose 7-phosphate, an intermediate within the pentose phosphate pathway. This process is catalyzed by two enzymes: a dimethyl 4-degadusol synthase (DDGS; MysA) and an Omethyltrans-ferase (O-MT; MysB). Subsequently, 4-DG undergoes a transformation into mycosporine-glycine(MG) through an ATP-grasp enzyme MysC, which introduces an amino acid moiety, primarily L-Gly. MAA analogues such as shinorine or porphyra-334 are further derived from MG by the D-Ala-D-Ala ligase-like enzyme MysD. In the final step, the biosynthesis is completed with a nonheme iron-(II)- and 2oxoglutarate-dependent (Fe/2OG) oxygenase MysH, leading to the production of palythines.
+
The biosynthetic route of MAA initiates with the generation of 4-deoxygadusol (4-DG) from sedoheptulose 7-phosphate, an intermediate within the pentose phosphate pathway. This process is catalyzed by two enzymes: a dimethyl 4-degadusol synthase (DDGS; MysA) and an Omethyltrans-ferase (O-MT; MysB). Subsequently, 4-DG undergoes a transformation into mycosporine-glycine(MG) through an ATP-grasp enzyme MysC, which introduces an amino acid moiety, primarily L-Gly. MAA analogues such as shinorine or porphyra-334 are further derived from MG by the D-Ala-D-Ala ligase-like enzyme MysD. In the final step, the biosynthesis is completed with a nonheme iron-(II)- and 2oxoglutarate-dependent (Fe/2OG) oxygenase MysH, leading to the production of palythines.
  
 
===Characterization===
 
===Characterization===
Line 23: Line 23:
 
| <html><img style="width:200px" src="https://static.igem.wiki/teams/4765/wiki/zsl/dna-gel/dhba.png" alt="contributed by Fudan iGEM 2023"></html>
 
| <html><img style="width:200px" src="https://static.igem.wiki/teams/4765/wiki/zsl/dna-gel/dhba.png" alt="contributed by Fudan iGEM 2023"></html>
 
|-
 
|-
| '''Figure 1. Agarose gel electrophoresis of PCR products, amplified from bacterial colonies/cultures.  
+
| '''Figure 2. Agarose gel electrophoresis of PCR products, amplified from bacterial colonies/cultures.  
 
From right lane(4) to left lane(1) indicate the successful construction of MysD, MysDH, MysDHB, and MysDHBA. '''
 
From right lane(4) to left lane(1) indicate the successful construction of MysD, MysDH, MysDHB, and MysDHBA. '''
  
Line 32: Line 32:
 
| <html><img style="width:200px" src="https://static.igem.wiki/teams/4765/wiki/zsl/protein-gel/dh5599-dh5600.png" alt="contributed by Fudan iGEM 2023"></html>
 
| <html><img style="width:200px" src="https://static.igem.wiki/teams/4765/wiki/zsl/protein-gel/dh5599-dh5600.png" alt="contributed by Fudan iGEM 2023"></html>
 
|-
 
|-
| '''Figure 2. SDS-PAGE electrophoresis of ribozyme connected: MysABCDH'''
+
| '''Figure 3. SDS-PAGE electrophoresis of ribozyme connected: MysABCDH'''
 
We successfully constructed MysDHB and MysDHA into the pET28a plasmid and transformed it into ''E. coli'' BL21 DE3. Lane 1 to 2 represents the IPTG uninduced and induced version of MysDHB.Lane 1 to 2 represents the IPTG uninduced and induced version of MysDHA. As indicated by the red arrow, we successfully expressed MysDHBA in this part.
 
We successfully constructed MysDHB and MysDHA into the pET28a plasmid and transformed it into ''E. coli'' BL21 DE3. Lane 1 to 2 represents the IPTG uninduced and induced version of MysDHB.Lane 1 to 2 represents the IPTG uninduced and induced version of MysDHA. As indicated by the red arrow, we successfully expressed MysDHBA in this part.
  
Line 42: Line 42:
 
| <html><img style="width:640px" src="https://static.igem.wiki/teams/4765/wiki/results-wyj/uv.jpg" alt="contributed by Fudan iGEM 2023"></html>
 
| <html><img style="width:640px" src="https://static.igem.wiki/teams/4765/wiki/results-wyj/uv.jpg" alt="contributed by Fudan iGEM 2023"></html>
 
|-
 
|-
| '''Figure 2. Anti-UV Assay.'''
+
| '''Figure 4. Anti-UV Assay.'''
  
 
|}
 
|}
 
''
 
''
Our experiments demonstrated that introducing three or four of the five enzymes from the MAA biosynthetic pathway into ''E. coli'' did not yield a significant enhancement in the bacterium's UV resistance. We postulate that this lack of effect may arise from two factors: Firstly, the synthetic pathway may not play a pivotal role amidst the numerous routes involved in MAA synthesis. Secondly, to augment MAA levels within E. coli through protein expression in the pathway, additional substrates like ATP and amino acids would likely be required in the reaction.
+
Our experiments demonstrated that introducing three or four of the five enzymes from the MAA biosynthetic pathway into ''E. coli'' did not yield a significant enhancement in the bacterium's UV resistance. We postulate that this lack of effect may arise from two factors: Firstly, the synthetic pathway may not play a pivotal role amidst the numerous routes involved in MAA synthesis. Secondly, to augment MAA levels within ''E. coli'' through protein expression in the pathway, additional substrates like ATP and amino acids would likely be required in the reaction.
  
 
{|
 
{|
 
| <html><img style="width:640px" src="https://static.igem.wiki/teams/4765/wiki/results-wyj/mysverification.png" alt="contributed by Fudan iGEM 2023"></html>
 
| <html><img style="width:640px" src="https://static.igem.wiki/teams/4765/wiki/results-wyj/mysverification.png" alt="contributed by Fudan iGEM 2023"></html>
 
|-
 
|-
| '''Figure 3. Plates displaying transformed E. coli after anti-UV assay.'''
+
| '''Figure 5. Plates displaying transformed ''E. coli'' after anti-UV assay.'''
  
 
|}
 
|}
Line 62: Line 62:
  
 
<!-- -->
 
<!-- -->
<span class='h3bb'>Sequence and Features</span>
+
===Sequence and Features===
 
<partinfo>BBa_K4765118 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K4765118 SequenceAndFeatures</partinfo>
  
Line 70: Line 70:
 
<partinfo>BBa_K4765118 parameters</partinfo>
 
<partinfo>BBa_K4765118 parameters</partinfo>
 
<!-- -->
 
<!-- -->
 
==Reference==
 

Latest revision as of 15:40, 12 October 2023


ribozyme connected: MysABCDH

contributed by Fudan iGEM 2023

Introduction

Mycosporine-like amino acids (MAAs), act as a sunscreen for the biofilm. This composite part contains five enyzmes in the MAA biosynthesis pathway. All the enzymes are constructed into ribozyme-assisted polycistronic co-expression system:pRAP.

contributed by Fudan iGEM 2023
Figure 1. The biosynthetic pathway of shinorine, porphyra-334, palythine-Ser, and palythine-Thr

Usage and Biology

The biosynthetic route of MAA initiates with the generation of 4-deoxygadusol (4-DG) from sedoheptulose 7-phosphate, an intermediate within the pentose phosphate pathway. This process is catalyzed by two enzymes: a dimethyl 4-degadusol synthase (DDGS; MysA) and an Omethyltrans-ferase (O-MT; MysB). Subsequently, 4-DG undergoes a transformation into mycosporine-glycine(MG) through an ATP-grasp enzyme MysC, which introduces an amino acid moiety, primarily L-Gly. MAA analogues such as shinorine or porphyra-334 are further derived from MG by the D-Ala-D-Ala ligase-like enzyme MysD. In the final step, the biosynthesis is completed with a nonheme iron-(II)- and 2oxoglutarate-dependent (Fe/2OG) oxygenase MysH, leading to the production of palythines.

Characterization

Agarose gel electrophoresis

contributed by Fudan iGEM 2023
Figure 2. Agarose gel electrophoresis of PCR products, amplified from bacterial colonies/cultures.

From right lane(4) to left lane(1) indicate the successful construction of MysD, MysDH, MysDHB, and MysDHBA.

Successful Protein Expression

contributed by Fudan iGEM 2023
Figure 3. SDS-PAGE electrophoresis of ribozyme connected: MysABCDH

We successfully constructed MysDHB and MysDHA into the pET28a plasmid and transformed it into E. coli BL21 DE3. Lane 1 to 2 represents the IPTG uninduced and induced version of MysDHB.Lane 1 to 2 represents the IPTG uninduced and induced version of MysDHA. As indicated by the red arrow, we successfully expressed MysDHBA in this part.


Anti-UV Survival Assay

We employed the Colony-Forming Unit (CFU) assay. After plasmid transformation and plating, we shielded one/half of the agar plate from UV light using a black paperboard, while the other one/half was exposed to UV irradiation (6W power) with wavelengths of 254 nm and 365 nm for 10 seconds.

contributed by Fudan iGEM 2023
Figure 4. Anti-UV Assay.

Our experiments demonstrated that introducing three or four of the five enzymes from the MAA biosynthetic pathway into E. coli did not yield a significant enhancement in the bacterium's UV resistance. We postulate that this lack of effect may arise from two factors: Firstly, the synthetic pathway may not play a pivotal role amidst the numerous routes involved in MAA synthesis. Secondly, to augment MAA levels within E. coli through protein expression in the pathway, additional substrates like ATP and amino acids would likely be required in the reaction.

contributed by Fudan iGEM 2023
Figure 5. Plates displaying transformed E. coli after anti-UV assay.



Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 1272
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 1064
    Illegal BsaI.rc site found at 2666
    Illegal BsaI.rc site found at 3785
    Illegal BsaI.rc site found at 5714